Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam Augmentation in OCD
NCT00299611Phase 3Terminated
- Sponsor
- Duke University
- Start
- Nov 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obsessive compulsive disorder (OCD) comparing Levetiracetam Arm with Placebo Arm (2 arms). Primary endpoint: Clinical Global Impression-Improvement at 24 weeks. Started Nov 2005; status: terminated.
02
Drugs
levetiracetam
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT00299611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299611.